rs142967124

Variant summary

Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_014363.6(SACS):​c.2983G>T​(p.Val995Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00221 in 1,611,978 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 9 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

2
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:11

Conservation

PhyloP100: -0.130
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.005890131).
BP6
Variant 13-23340893-C-A is Benign according to our data. Variant chr13-23340893-C-A is described in ClinVar as [Likely_benign]. Clinvar id is 218707.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr13-23340893-C-A is described in Lovd as [Likely_benign].
BS2
High Homozygotes in GnomAdExome4 at 9 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SACSNM_014363.6 linkuse as main transcriptc.2983G>T p.Val995Phe missense_variant 10/10 ENST00000382292.9 NP_055178.3 Q9NZJ4-1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SACSENST00000382292.9 linkuse as main transcriptc.2983G>T p.Val995Phe missense_variant 10/105 NM_014363.6 ENSP00000371729.3 Q9NZJ4-1

Frequencies

GnomAD3 genomes
AF:
0.00172
AC:
262
AN:
152176
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000386
Gnomad AMI
AF:
0.0132
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.000865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00186
Gnomad FIN
AF:
0.000660
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00275
Gnomad OTH
AF:
0.00191
GnomAD3 exomes
AF:
0.00185
AC:
465
AN:
250846
Hom.:
4
AF XY:
0.00199
AC XY:
270
AN XY:
135588
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00116
Gnomad ASJ exome
AF:
0.00149
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00233
Gnomad FIN exome
AF:
0.000786
Gnomad NFE exome
AF:
0.00269
Gnomad OTH exome
AF:
0.00229
GnomAD4 exome
AF:
0.00227
AC:
3308
AN:
1459686
Hom.:
9
Cov.:
36
AF XY:
0.00232
AC XY:
1681
AN XY:
725738
show subpopulations
Gnomad4 AFR exome
AF:
0.000299
Gnomad4 AMR exome
AF:
0.00121
Gnomad4 ASJ exome
AF:
0.00188
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00221
Gnomad4 FIN exome
AF:
0.00101
Gnomad4 NFE exome
AF:
0.00257
Gnomad4 OTH exome
AF:
0.00144
GnomAD4 genome
AF:
0.00172
AC:
262
AN:
152292
Hom.:
1
Cov.:
32
AF XY:
0.00158
AC XY:
118
AN XY:
74466
show subpopulations
Gnomad4 AFR
AF:
0.000385
Gnomad4 AMR
AF:
0.00157
Gnomad4 ASJ
AF:
0.000865
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00187
Gnomad4 FIN
AF:
0.000660
Gnomad4 NFE
AF:
0.00275
Gnomad4 OTH
AF:
0.00189
Alfa
AF:
0.00221
Hom.:
1
Bravo
AF:
0.00175
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00285
AC:
11
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00244
AC:
21
ExAC
AF:
0.00201
AC:
244
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:11
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Likely benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 21, 2016- -
Likely benign, criteria provided, single submitterclinical testingGenomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of PhiladelphiaJul 17, 2015- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJan 02, 2020- -
not provided Benign:3
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenMar 01, 2024SACS: BP4, BS2 -
Likely benign, criteria provided, single submitterclinical testingGeneDxOct 01, 2020This variant is associated with the following publications: (PMID: 29482223, 19779133, 23497566) -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Charlevoix-Saguenay spastic ataxia Benign:3
Likely benign, no assertion criteria providedclinical testingNatera, Inc.Sep 25, 2020- -
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaApr 27, 2017This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases allowed determination this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -
Likely benign, criteria provided, single submitterclinical testingGenome-Nilou LabMay 18, 2021- -
Spastic paraplegia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Hereditary spastic paraplegia Benign:1
Likely benign, criteria provided, single submitterclinical testingGenome Diagnostics Laboratory, The Hospital for Sick ChildrenJan 01, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.31
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
10
DANN
Benign
0.95
DEOGEN2
Benign
0.22
.;T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.4
FATHMM_MKL
Benign
0.23
N
LIST_S2
Benign
0.84
T;T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.0059
T;T
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
0.69
.;N
PrimateAI
Benign
0.33
T
PROVEAN
Benign
-1.2
N;N
REVEL
Benign
0.26
Sift
Uncertain
0.0080
D;D
Sift4G
Uncertain
0.011
D;D
Polyphen
0.0020
.;B
Vest4
0.30
MVP
0.34
ClinPred
0.011
T
GERP RS
-6.8
Varity_R
0.12
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs142967124; hg19: chr13-23915032; API